Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Bioorganic Chemistry|June 3, 2016
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agentsIbrahim H Eissa, Abeer M El-Naggar, Maher A El-HashashArchiv Der Pharmazie|February 23, 2022
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular dockingIbrahim H Eissa, Mohamed-Kamal Ibrahim, Mohamed S Alesawy, et al.Bioorganic Chemistry|May 4, 2019
Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducersSouad A Elmetwally, Khaled F Saied, Ibrahim H Eissa, et al.Molecules (Basel, Switzerland)|July 27, 2022
The Inhibitory Potential of 2'-dihalo Ribonucleotides against HCV: Molecular Docking, Molecular Simulations, MM-BPSA, and DFT StudiesAhmed Khalil, Amany S El-Khouly, Eslam B Elkaeed, et al.Archiv Der Pharmazie|March 16, 2022
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluationsKhaled El-Adl, Mohamed-Kamal Ibrahim, Mohamed S Alesawy, et al.Archiv Der Pharmazie|January 11, 2022
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3-c]quinazolines as classical DNA intercalatorsMohamed S Alesawy, Mohamed-Kamal Ibrahim, Ibrahim H Eissa, et al.RSC Advances|May 2, 2022
Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding siteAbeer M El-Naggar, Ibrahim H Eissa, Amany Belal, et al.Bioorganic & Medicinal Chemistry|December 28, 2020
[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studiesKhaled El-Adl, Mohamed-Kamal Ibrahim, Mohammed S I Alesawy, et al.Archiv Der Pharmazie|August 19, 2021
Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluationsFathalla Khedr, Mohamed-Kamal Ibrahim, Ibrahim H Eissa, et al.Archiv Der Pharmazie|October 1, 2021
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitorsKhaled El-Adl, Mohamed K Ibrahim, Fathalla Khedr, et al.Pageof 17